Country: Canada
Language: English
Source: Health Canada
ACETAMINOPHEN; CAFFEINE CITRATE; CODEINE PHOSPHATE
PHARMASCIENCE INC
N02AJ06
CODEINE AND PARACETAMOL
300MG; 30MG; 30MG
TABLET
ACETAMINOPHEN 300MG; CAFFEINE CITRATE 30MG; CODEINE PHOSPHATE 30MG
ORAL
500
Narcotic (CDSA I)
OPIATE AGONISTS
Active ingredient group (AIG) number: 0302037004; AHFS:
CANCELLED POST MARKET
2016-07-14
PRESCRIBING INFORMATION N EXDOL-8 ® ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (8 MG) TABLETS N EXDOL-15 ® ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (15 MG) TABLETS N EXDOL-30 ® ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (30 MG) TABLETS ANALGESIC - ANTIPYRETIC PHARMASCIENCE INC. 6111 Royalmount Ave., Suite #100 Montréal, Québec H4P 2T4 Date of Revision: March 25, 2014 www.pharmascience.com Submission Control: 172010 ® EXDOL-8, EXDOL-15 and EXDOL-30 are registered trademarks of Pharmascience Inc. _EXDOL-8, EXDOL-15 _ _ EXDOL-30 Prescribing Information _ _Page 2 of 9_ PRESCRIBING INFORMATION N EXDOL-8 ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (8 MG), TABLETS N EXDOL-15 ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (15 MG), TABLETS N EXDOL-30 ACETAMINOPHEN (300 MG), CAFFEINE CITRATE (30 MG), CODEINE PHOSPHATE (30 MG), TABLETS ANALGESIC - ANTIPYRETIC INDICATIONS For the relief of mild to moderate pain and the reduction of fever in adults 18 years and older. CLINICAL USES EXDOL is valuable as a non-salicylate analgesic for the relief of pain in a wide variety of arthritic and rheumatic conditions involving musculoskeletal pain as well as in myalgia, neuralgia, headache, toothache and dysmenorrhea; as an antipyretic for symptomatic reduction of fever. EXDOL is particularly useful for patients who must avoid the gastric irritation caused by acetylsalicylic acid (such as patients with peptic ulcer, gastritis, hiatus hernia, reflux esophagitis and patients on steroid therapy); for patients allergic to acetylsalicylic acid; for patients with bleeding disorders or on anticoagulant therapy. PEDIATRICS Regardless of clinical setting, the use of codeine, including EXDOL, is not recommended in patients below the age of 18 years due to increased safety concerns. _EXDOL-8, EXDOL-15 _ _ EXDOL-30 Prescribing Information _ _Page 3 of 9_ CONTRAINDICATIONS Sensitivity to any of the components. Repea Read the complete document